Literature DB >> 35072892

Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.

Junfei Gu1, Ruolan Sun1, Decai Tang1, Fuyan Liu1, Xiangwei Chang2, Qiaohan Wang3.   

Abstract

Colorectal cancer (CRC) is regarded as one of the commonest cancer types around the world. Due to the poor understanding on the causes of CRC formation and progression, this study sets out to investigate the physiological mechanisms by which Astragalus mongholicus Bunge-Curcuma aromatica Salisb. (ARCR) regulates CRC growth and metastasis, and the role in which M2 macrophage polarization plays in this process. An orthotopic-transplant model of CRC was established to evaluate the influence of ARCR on the polarization of M2 macrophage and the growth and metastasis of tumors. Next, the binding affinity among Sp1, ZFAS1, miR-153-5p, and CCR5 was identified using multiple assays. Finally, after co-culture of bone marrow-derived macrophages (BMDM) with CRC cell line CT26.WT, the cell proliferative, invasive, and migrated abilities were assessed in gain- or loss-of-function experiments. ARCR inhibited the infiltration of M2 macrophages into tumor microenvironment to suppress the CRC growth and metastasis in vivo. Additionally, ARCR inhibited the transcription of ZFAS1 by reducing Sp1 expression to repress M2 macrophage polarization. Moreover, ZFAS1 competitively binds to miR-153-3p to upregulate the CCR5 expression. Finally, ARCR suppressed the polarization of M2 macrophages to inhibit the tumor growth and tumor metastasis in CRC by mediating the Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis. Collectively, ARCR appears to suppress the CRC cell growth and metastasis by suppressing M2 macrophage polarization via Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis. 1. ARCR suppress the CRC cell growth and metastasis 2. ZFAS1 promotes CCR5 expression by competitively binding to miR-153-3p. 3. Sp1 promotes M2 macrophage polarization by activating ZFAS1 via miR-153-3p/CCR5. 4. The study unveiled a protective target against CRC.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Astragalus mongholicus Bunge-Curcuma aromatica Salisb; CCR5; Colorectal cancer; M2 macrophage polarization; Sp1; ZFAS1; miR-153-3p

Mesh:

Substances:

Year:  2022        PMID: 35072892     DOI: 10.1007/s10565-021-09679-w

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.819


  38 in total

1.  The main active components of Curcuma zedoaria reduces collagen deposition in human lung fibroblast via autophagy.

Authors:  Sun Chun-Bin; Ying Yi; Wu Qin-Yi; Liu Yang; Yu Jing-Ze; Xing Hai-Jing; Zhang Si-Qi; Hou Jiong; Wen Jing; Liu Fei-Yu; Yan Jin-Yuan; Yuan Jia-Li; Zhong-Shan Yang
Journal:  Mol Immunol       Date:  2020-06-15       Impact factor: 4.407

2.  Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.

Authors:  Li-Yuan Chang; Yung-Chang Lin; Jayashri Mahalingam; Ching-Tai Huang; Ten-Wen Chen; Chiao-Wen Kang; Hui-Min Peng; Yu-Yi Chu; Jy-Ming Chiang; Avijit Dutta; Yuan-Ji Day; Tse-Ching Chen; Chau-Ting Yeh; Chun-Yen Lin
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

Review 3.  Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: A meta-analysis of the contributions of specific plants.

Authors:  Menghua Chen; Brian H May; Iris W Zhou; Daniel Man-Yuen Sze; Charlie C Xue; Anthony L Zhang
Journal:  Crit Rev Oncol Hematol       Date:  2016-07-07       Impact factor: 6.312

4.  Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.

Authors:  Dan Dong; Zhongyi Mu; Ning Wei; Mingli Sun; Wei Wang; Na Xin; Yue Shao; Chenghai Zhao
Journal:  Biomed Pharmacother       Date:  2019-01-07       Impact factor: 6.529

5.  Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer.

Authors:  Gizem Calibasi-Kocal; Ahu Pakdemirli; Serdar Bayrak; Nazli Mert Ozupek; Tolga Sever; Yasemin Basbinar; Hulya Ellidokuz; Turkan Yigitbasi
Journal:  J BUON       Date:  2019 Jul-Aug       Impact factor: 2.533

6.  ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs.

Authors:  Xiaolu Cui; Chiyuan Piao; Chengcheng Lv; Xuyong Lin; Zhe Zhang; Xiankui Liu
Journal:  Cell Mol Life Sci       Date:  2019-07-18       Impact factor: 9.261

7.  CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis.

Authors:  Yan Cheng; Jing Wu; Bin Qin; Bai-Cang Zou; Yong-Hua Wang; Yang Li
Journal:  Biochem Biophys Res Commun       Date:  2020-04-02       Impact factor: 3.575

8.  miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Authors:  Qian Huang; Jiajia Xia; Lei Wang; Xu Wang; Xiaodong Ma; Qipan Deng; Yong Lu; Munish Kumar; Zhiyuan Zhou; Ling Li; Zhaoyang Zeng; Ken H Young; Qing Yi; Mingzhi Zhang; Yong Li
Journal:  J Hematol Oncol       Date:  2018-04-23       Impact factor: 17.388

9.  The extracts of Astragalus membranaceus overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression.

Authors:  Hsu-Liang Chang; Yi-Hsuan Kuo; Li-Hsien Wu; Chih-Min Chang; Kai-Jen Cheng; Yu-Chang Tyan; Che-Hsin Lee
Journal:  Int J Med Sci       Date:  2020-03-26       Impact factor: 3.738

10.  SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis.

Authors:  Xiaoxiang Chen; Kaixuan Zeng; Mu Xu; Xiuxiu Hu; Xiangxiang Liu; Tao Xu; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

View more
  2 in total

1.  Identification and functional analysis of LncRNA-XIST ceRNA network in prostate cancer.

Authors:  Jie Wang; Jie Huang; Yingxue Guo; Yuli Fu; Yifang Cao; Kang Zhou; Jianxiong Ma; Bodong Lv; Wenjie Huang
Journal:  BMC Cancer       Date:  2022-08-29       Impact factor: 4.638

Review 2.  Astragalus Mongholicus: A review of its anti-fibrosis properties.

Authors:  Fengying Gong; Rongmei Qu; Yongchun Li; Ying Lv; Jingxing Dai
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.